Alemtuzumab Intravenous and Buprenorphine Sublingual Tablets
Determining the interaction of Alemtuzumab Intravenous and Buprenorphine Sublingual Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: alemtuzumab
Brand name: Campath, Lemtrada
Synonyms: Alemtuzumab
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Alemtuzumab Intravenous-Buprenorphine Transdermal
- Alemtuzumab Intravenous-Buprenorphine Transdermal Patch
- Alemtuzumab Intravenous-Buprenorphine transdermal skin patch
- Alemtuzumab Intravenous-Buprenorphine, Buprenorphine Hydrochloride
- Alemtuzumab Intravenous-Buprenorphine/naloxone Oromucosal, Sublingual
- Alemtuzumab Intravenous-Buproban
- Buprenorphine Sublingual Tablets-Alenaze-D
- Buprenorphine Sublingual Tablets-Alendronate
- Buprenorphine Sublingual Tablets-Alendronate and cholecalciferol
- Buprenorphine Sublingual Tablets-Alendronate Effervescent Tablets
- Buprenorphine Sublingual Tablets-Alendronate Oral Solution
- Buprenorphine Sublingual Tablets-Alendronate Sodium